Pershing Square

Valeant Shares May Hit the Rocks

Valeant Shares May Hit the Rocks

6 mins. to read

…and so may activist investor Bill Ackman. Short-seller turned activist investor Bill Ackman has just recorded a $2 billion write-down on his portfolio due to a failed bet on the Canadian drugmaker Valeant Pharmaceuticals. But he promises to fight back, as he still believes he can build value in the company. In the 13F form…


Get real investment insights from some of the best minds in the business - with our free Master Investor Magazine.